BMC Cancer (Sep 2023)

The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer

  • Xin Luo,
  • Xianchao Lin,
  • Ronggui Lin,
  • Yuanyuan Yang,
  • Congfei Wang,
  • Haizong Fang,
  • Heguang Huang,
  • Fengchun Lu

DOI
https://doi.org/10.1186/s12885-023-11346-8
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background The relationship between postoperative CA125 level changes and early recurrence after curative resection of resectable PDAC is still unclear. Methods The electronic medical records and follow-up data of patients with resectable pancreatic cancer were evaluated. Dynamic CA125 detection was used to identify the rules for postoperative CA125 level change and its prognostic value in patients with resectable pancreatic cancer. Results The study included a total of 118 patients with resectable pancreatic cancer who underwent curative resection. Early postoperative CA125 levels were significantly higher than those before surgery (P 0.05). There was no correlation between early postoperative CA125 levels and early recurrence (P > 0.05). CA125 levels three months after surgery were associated with an increased risk of early recurrence (P = 0.038, 95% CI (1.001–1.025)). The cutoff CA125 level at 3 months after surgery for predicting early recurrence was 22.035. Patients with CA125 levels 22.035 at 3 months postoperatively (p 3 months postoperatively, rather than early postoperative elevation, were associated with a poor prognosis.

Keywords